George Soros's CPRX Position Overview
George Soros (via Soros Fund Management LLC) currently holds 344,593 shares of Catalyst Pharmaceuticals, Inc. (CPRX) worth $10.83 M, representing 0.13% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in CPRX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Catalyst Pharmaceuticals (CPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Catalyst Pharmaceuticals (CPRX) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +344,593 | New Buy | 344,593 | $31.43 |
George Soros's Catalyst Pharmaceuticals Investment FAQs
George Soros first purchased Catalyst Pharmaceuticals, Inc. (CPRX) in Q2 2026, acquiring 344,593 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Catalyst Pharmaceuticals, Inc. (CPRX) for 1 quarters since Q2 2026.
George Soros's largest addition to Catalyst Pharmaceuticals, Inc. (CPRX) was in Q2 2026, adding 344,593 shares worth $10.83 M.
According to the latest 13F filing for Q2 2026, George Soros's firm, Soros Fund Management LLC, owns 344,593 shares of Catalyst Pharmaceuticals, Inc. (CPRX), valued at approximately $10.83 M.
As of the Q2 2026 filing, Catalyst Pharmaceuticals, Inc. (CPRX) represents approximately 0.13% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Catalyst Pharmaceuticals, Inc. (CPRX) was 344,593 shares, as reported at the end of Q2 2026.